- Home
- NL vs SAGE Comparison
NL vs SAGE Comparison
Compare NL & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- SAGE
- Stock Information
- Founded
- NL 1891
- SAGE 2010
- Country
- NL United States
- SAGE United States
- Employees
- NL N/A
- SAGE N/A
- Industry
- NL Major Chemicals
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- SAGE Health Care
- Exchange
- NL Nasdaq
- SAGE Nasdaq
- Market Cap
- NL 362.9M
- SAGE 415.0M
- IPO Year
- NL N/A
- SAGE 2014
- Fundamental
- Price
- NL $8.05
- SAGE $6.56
- Analyst Decision
- NL Sell
- SAGE Hold
- Analyst Count
- NL 1
- SAGE 19
- Target Price
- NL $6.00
- SAGE $9.88
- AVG Volume (30 Days)
- NL 26.3K
- SAGE 930.8K
- Earning Date
- NL 05-07-2025
- SAGE 04-29-2025
- Dividend Yield
- NL 4.46%
- SAGE N/A
- EPS Growth
- NL 441.25
- SAGE N/A
- EPS
- NL 1.25
- SAGE N/A
- Revenue
- NL $148,242,000.00
- SAGE $47,404,000.00
- Revenue This Year
- NL $15.75
- SAGE $100.64
- Revenue Next Year
- NL $2.44
- SAGE $70.19
- P/E Ratio
- NL $6.47
- SAGE N/A
- Revenue Growth
- NL N/A
- SAGE N/A
- 52 Week Low
- NL $5.20
- SAGE $4.62
- 52 Week High
- NL $9.42
- SAGE $14.56
- Technical
- Relative Strength Index (RSI)
- NL 48.23
- SAGE 32.75
- Support Level
- NL $8.22
- SAGE $7.23
- Resistance Level
- NL $9.27
- SAGE $7.63
- Average True Range (ATR)
- NL 0.40
- SAGE 0.29
- MACD
- NL -0.01
- SAGE -0.10
- Stochastic Oscillator
- NL 28.24
- SAGE 3.96
About NL NL Industries Inc.
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.